Metformin and N-terminal pro B-type natriuretic peptide in type 2 diabetes patients, a post-hoc analysis of a randomized controlled trial

BACKGROUND: Beyond antihyperglycemic effects, metformin may improve cardiovascular outcomes. Patients with type 2 diabetes often have an elevated plasma level of N-terminal pro B-type as a marker of (sub) clinical cardiovascular disease. We studied whether metformin was associated with a reduction i...

Descripción completa

Detalles Bibliográficos
Autores principales: Top, Wiebe M. C., Lehert, Philippe, Schalkwijk, Casper G., Stehouwer, Coen D. A., Kooy, Adriaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031400/
https://www.ncbi.nlm.nih.gov/pubmed/33830998
http://dx.doi.org/10.1371/journal.pone.0247939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031400/
https://www.ncbi.nlm.nih.gov/pubmed/33830998
http://dx.doi.org/10.1371/journal.pone.0247939

Ejemplares similares